← Leaderboards
Melissa Ann Geller
University Of Minnesota
$2,938,539
Attributed
$2,938,539
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2009–25$2M$1.5M$1M$500K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$2,938,539 · 3
By mechanism
P01$1,756,845 · 1
P30$1,173,644 · 1
M01$8,050 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Minnesota
Same institution · by research overlap
- Jeffrey S Miller$32,066,338
- Brenda J. Weigel$37,619,294
- Martin Felices$2,733,593
- John E Wagner$7,593,142
- Emily Chiu$133,733
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsMinnesotaUniversitiesWomanClinical TrialsProgramsRecurrenceMalignant Neoplasm Of OvaryAllogenicInterleukin-2Natural Killer CellsAntitumor EffectAntibodiesCancer CellBlood Component RemovalBloodAntigensClinical EfficacyBindingCellsCancer TherapyCd276 GeneCd32 AntigensCancer Stem Cell
Grant awards (8)
Clinical Protocol and Data Management$499,769
P30 · FY2025 · CA · contact PI
Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance$387,581
P01 · FY2025 · CA · contact PI
Clinical Protocol and Data Management$673,875
P30 · FY2024 · CA · contact PI
Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance$347,612
P01 · FY2024 · CA · contact PI
Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance$369,059
P01 · FY2023 · CA · contact PI
Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance$358,589
P01 · FY2022 · CA · contact PI
Locally Targeted Off-The-Shelf NK Cells For Ovarian Cance$294,004
P01 · FY2021 · CA · contact PI
MT2007-19R: WCC #53 ALLOGENEIC NATURAL KILLER CELLS IN PATIENTS WITH RECURRENT O$8,050
M01 · FY2009 · RR · contact PI